Tarsus Pharmaceuticals To Present 11 Abstracts On XDEMVY, Demodex Blepharitis, And Ocular Rosacea At American Academy Of Optometry Meeting
Share
Why It Matters
Tarsus is showing research about its eye medicine XDEMVY at a big meeting. This is a chance for doctors to learn more about how well it works.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.